Release Date: 28/10/11 09:45 Summary: HeartWare Announces Third Quarter Revenues of US$21.3 M Price Sensitive: Yes Download Document 255.7KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status